Back to Top

Information For Authors

Submitting Your Manuscript

Autism in Adulthood is published by Mary Ann Liebert, Inc. publishers. The founding Editor-in-Chief is Christina Nicolaidis, MD, MPH. The Journal is managed by an academic chief editor, associate editors, and an international editorial board comprised of leading researchers, autistic community leaders, and practitioners focused on autism in adulthood.

CLICK HERE FOR ARTICLE TYPES AND WORD LIMITS

Use of Language

Anti-ableist language

Autism in Adulthood strives to use anti-ableist language throughout. Please CLICK HERE to review the recommendations in Avoiding Ableist Language: Suggestions for Autism Researchers.

Terms related to autism and disability

The language used to describe autism can greatly affect people on the spectrum, and how society views them. Autism in Adulthood recommends authors consider the following recommendations.

Person-first vs. identity-first language

Autism in Adulthood respects that there are strong arguments and passions on both sides of the debate between the use of person-first language (e.g., “person with autism”) and identity-first language (e.g., “autistic person”) in relation to autism. However, there is a growing body of scientific and community literature documenting the dislike, amongst autistic individuals, of person-first language and its potential for increasing stigma.1-4 Based on this literature and the strong preference of the autistic members of the journal’s Editorial Board, we recommend either using identity-first language, or more neutral terms such as "person on the autism spectrum.”
For more information about the use of identity-first language, see:

  1. Gernsbacher MA. Editorial perspective: the use of person-first language in scholarly writing may accentuate stigma. J Child Psychol Psychiatry. 2017;58(7):859-861.
  2. Kapp SK, Gillespie-Lynch K, Sherman LE, Hutman T. Deficit, difference, or both? Autism and neurodiversity. Dev Psychol. 2013;49(1):59-71.
  3. Kenny L, Hattersley C, Molins B, Buckley C, Povey C, Pellicano E. Which terms should be used to describe autism? Perspectives from the UK autism community. Autism. 2016;20(4):442-462.
  4.  Sinclair J. Why I dislike "person first" language. 1999.  http://web.archive.org/web/20080616063934/http://web.syr.edu/~jisincla/person_first.htm. Last accessed September 10, 2020.

Subpopulations within the autism spectrum
Due to the ambiguity and potential offensiveness of terms such as “high functioning” or “low functioning” autism, “Kanner's” autism, or "mild" or "severe" autism, Autism in Adulthood recommends avoiding these terms. Instead, describe subpopulations using the specific characteristic(s) that make them a subpopulation. For example, "autistic people who qualify for developmental disability services," or "autistic people who primarily communicate using speech."

Terms related to autism diagnoses

The term “Autism Spectrum Disorder” (ASD) may be used when specifically discussing autism diagnoses. Otherwise, we recommend using terms such as “autism,” “autism spectrum,” “autistic adults,” or “autistic participants.” When referring to historic data, historic diagnoses such as Asperger's syndrome may be used; however, these terms should be considered out of date, and not used as terms for any part of the autism spectrum except when referring to someone’s self-identity.

Strengths-based vs. deficits-based language

Autism in Adulthood strongly encourages authors to take a strengths-based approach to writing about autism. Examples include:

  • Referring to autism as a condition or disability instead of as a disease or illness;
  • Using neutral terms such as "typically developing" or “non-autistic” rather than "healthy" or “normal;”
  • Avoiding emotional phrases such as "suffering from autism;"
  • Referring to “co-occurring” or “secondary” conditions instead of “comorbid” conditions;
  • Referring to autistic characteristics in a neutral or positive manner, as opposed to as symptoms or deficits (e.g., “autistic traits,” “characteristics of autism,” or “features of autism” instead of “symptoms of autism”; “communication differences” instead of “communication deficits”).

General guidelines for writing about disability more broadly

There are many excellent guides to writing about disability more broadly. Authors may refer to resources from the following organizations:

The Editors of Autism in Adulthood welcome questions by authors regarding language. We understand that language can be a gray area, can vary by geography and culture, and that there are many valid opinions. Contact the Editor at AutismInAdulthood@pdx.edu for further guidance.

Use of active voice and concise language
Autism in Adulthood recommends the use of the active voice as opposed to the passive voice. Further, we recommend that the actor in a sentence always be explicitly identified for clarity. For example: “A research assistant administered the surveys.” (Not: “Surveys were administered.”) Autism in Adulthood also recommends use of clear, concise language. Avoid using sentences with excessive clauses or unnecessary complexity.

Use of English Language
All submissions must be in English. Appropriate use of English is a requirement for review and publication in Autism in Adulthood. To support non-native speakers, Mary Ann Liebert, Inc., has partnered with Editage to provide language editing and translation services for a fee prior to official submission. To learn more about the services, please visit the Liebert Author Services website. Please note that employing the use of such services is not mandatory and using it, or any other language editing service, does not guarantee the acceptance of any paper. All submissions are subject to peer review.

ORCID IDs

The submitting author is required to complete the submission using an ORCID identifier. Please visit the ORCID website for more information, or to register.  You must have an account in ScholarOne  Autism in Adulthood before logging in with an ORCID identifier.

Manuscript Submission Site

Create an Account in ScholarOne

If you do not already have an account in ScholarOne for Autism in Adulthood, you will need to create one.  Once you create your account, you may log in to the system to begin your submission. Each listed author on a submission must either have an account, or have one created, in the submission system.

CLICK HERE TO SUBMIT YOUR MANUSCRIPT

See JOURNAL STANDARDS AND BEST PRACTICES STATEMENT

Check the Journal’s PEER REVIEW POLICIES

Manuscript Preparation

Determining Authorship

(See AUTHORSHIP DEFINITION AND RESPONSIBILITIES)

All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a manuscript assumes responsibility and accountability for the results.

Third-Party Submissions
 

Please note that if manuscripts are submitted by third parties (i.e., editing services or other agents), those third parties must submit the manuscript as a submitting agent, using a corporate or official email account. In addition, the name and company of the submitting agent must be disclosed in the cover letter. Authors are responsible for manuscripts submitted by third parties. If we determine that a non-disclosed third party submitted the manuscript without following these procedures, we reserve the right to immediately reject the manuscript.

Submission Process

All Original submissions must contain:

  •   An Institutional Review Board (IRB) approval (or waiver) statement in the Methods section
  •   Acknowledgments section (if applicable) after the Conclusion of the manuscript, followed by
  •   An Author Contribution statement for each listed author, followed by
  •  An Author Disclosure Statement for each author listed on a submission, even if there are no conflicts to disclose, followed by,
  • Funding statement(s), even if there is no funding information to declare.

See IRB APPROVALS, PATIENT CONSENT, & ETHICAL TREATMENT OF ANIMALS

See AUTHOR CONFIRMATION AND DISCLOSURE STATEMENTS

See FUNDING INFORMATION: COMPLIANCE AND STATEMENTS

Human Subjects: Patient Consent/Release

If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients. The Journal does not provide a generic patient release form. Any identifying information should not be published in descriptions or photographs unless the information is essential for scientific purposes and the patient (or parent/guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be submitted. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, the manuscript should contain assurances/statements that such changes do not distort scientific meaning.

In keeping with patients' rights of privacy, the Journal does not require the submission of patient consent forms, but instead requires the author(s) to retain and archive all patient consent documentation. Upon submission of a manuscript for review, the authors must make a statement in a cover letter to the Editor/Journal which attests that they have received and archived written patient consent.

All manuscripts must be prepared in accordance with the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations).

When submitting your manuscript for peer review, be prepared to:

  • Provide a cover letter
  • Enter the full title of the manuscript
  • Enter the full names and institutional affiliations of ALL listed authors
  • Enter ALL listed authors' institutional email addresses
  • Identify the corresponding author
  • Enter a running (abbreviated) title of no more than 45 characters (including spaces).
  • Enter 3–6 keywords or phrases to assist in the selection of skilled reviewers in the field for the purposes of peer review.
  • Provide a structured OR unstructured abstract (see further details in the Abstract section below)
  • Confirm that the material has not been published or submitted for publication elsewhere.   

Note: There is a total limit of 350 MB per submission.

Cover Letter

Submit a cover letter addressed to the Editor with each manuscript. Include a brief overview of the manuscript (including title, design, and major findings), and explain why the manuscript would be of interest to the readers of Autism in Adulthood and how it would impact the field. As appropriate, include additional information that would help the Editors place this study in the context of other work (e.g., if the manuscript describes one specific analysis from a larger study, explain how this manuscript fits in with other articles, where other articles have been published, and describe the stage of preparation of other planned manuscripts). If part of the manuscript information has been published previously, please indicate where it was published, and the extent of overlap with this manuscript. Attach a copy of the articles (or manuscripts) in question.

Create an Effective Title

  • Manuscript titles should be brief, contain key terms, and clearly identify the purpose of the work conducted
  • Manuscript titles should not exceed 15 -18 words. Exceptions can be made with the Editor’s approval
  • Manuscript titles should be direct and to the point. Remember that the journal has a global readership, so clear and concise non-vernacular language is most effective
  • Avoid the use of specific locations in the title
  • Do not use proprietary/trademarked names in the title
  • Do not use acronyms in the title unless they are universally recognized and accepted
  • Avoid using the title to make declarative statements about the results of the study. For example, instead of “X is Related to Y in Autistic Adults,” use titles such as “The Association Between X and Y in Autistic Adults: Results from a Prospective Cohort Study.”
  • NOTE: The title page of your submission must be included as part of your main text document (not as a separate file). 

File Naming

All file names should be in English and contain only alphanumeric characters.  Do not include spaces, symbols, special characters, dashes, dots, or underscores.  Label each file with the type of content contained in the file (i.e.: Text; Tables; FigureLegends; Fig1, Fig2, etc.)

Important:  Please upload individual files of all manuscript material as described herein — please do NOT upload a combined PDF file containing all material in your submission.  

Preparation of Manuscript

Prepare text of manuscripts, figure legends, and tables in Microsoft Word, double spaced. The order of elements in each manuscript should be:

  • Title page, included as part of the main text document (with full manuscript title, all contributing authors’ full names, degrees, complete affiliations, and email addresses; a short running title; a denotation of the corresponding author with their complete contact information including address and email address; the study registry number, if applicable; and a list of 3-6 keywords). Include the word count for the abstract; word count for the main text; and word count for the lay summary.
  •  Abstract
  • Main text (do not embed figures or tables)
  • Conclusion (if applicable; as a separate paragraph, not as part of the Discussion section)
  • Acknowledgments (if applicable)
  • Authorship confirmation statement (see below)
  • Author(s’) disclosure statement(s) (see below)
  • Funding statement (see below)
  • References
  • Figure legends
  • Tables
  • Supplemental Information (if applicable; NOTE: Supplemental Information will not be copyedited or typeset; it will be posted online as supplied.)

Note: The keywords are search terms that will aid in the discoverability of the article in indexing services and search engines. These terms may or may not be different from the terms you select for the peer review process and areas of expertise. These keywords will be included in the published article.

Authorship Confirmation Statement

This statement should include a paragraph detailing each listed authors’ contributions to and responsibilities for the manuscript. This text should also contain a statement that all co-authors have reviewed and approved of the manuscript prior to submission. Lastly, include a confirmation statement that the manuscript has been submitted solely to this journal and is not published, in press, or submitted elsewhere (posting on a non-peer-reviewed preprint server does not constitute prior publication).

Refer to the Publisher Policies for information regarding qualifications on authorship vs. contributorship.
 
Author Disclosure Statements

On a separate page within the manuscript file, following the Authorship Confirmation Statement page, include any financial conflicts of interest, actual or potential, for each listed author on the submission. If no conflicts exist, the authors must state, “No competing financial interests exist.” Articles submitted without Author Disclosure Statements will be un-submitted so that a statement may be added.

Refer to the Publisher Policies for further information.

Abstract

  • The abstract must be included as part of the main text file
  • Please refer to the Article Types and Word Limits for information regarding whether the abstract should be structured or unstructured and for the abstract word limits.
  • Prepare the abstract on a separate page to be included after the title page
  • References are not permitted in the abstract.
  • Do not use proprietary or trade names in the abstract.
  • For manuscript types requiring a structured abstract, use the following headings: Background, Methods, Results, and Conclusions.
  • For manuscript types requiring an unstructured abstract, the abstract should briefly summarize the background and rationale and clearly summarize the findings and/or conclusions of the work.

Manuscript Text

Original Research Articles and Brief Research Reports

The main text should use the following headings: Introduction; Methods; Results; and Discussion. The Discussion section should include (in the following order) a discussion of the study conclusions, how the study compares to and advances the existing literature, limitations, and implications (to individuals, practitioners, systems, policy, and/or research).

To ensure that studies with various methods have the highest quality reporting, Autism in Adulthood strongly suggests that authors use standard formats as described at http://www.equator-network.org  (i.e., CONSORT for randomized trials, STROBE for observational studies, and SQUIRE for quality improvement studies, etc.). Authors are strongly encouraged to use the checklists offered for these guidelines. The Editor(s) may request those checklists during the manuscript review process.
Clinical Trials Registration: Autism in Adulthood ascribes to the registration policies of the International Committee of Medical Journal Editors (ICMJE) that can be found at http://www.icmje.org/about-icmje/faqs/clinical-trials-registration Appropriate registries (such as www.clinicaltrials.gov) must be accessible to the public at no charge and must be open to all prospective registrants and managed by a not-for-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. Please include the appropriate Trial Registration Number on the Title Page of the submitted manuscript.

Conceptual Analyses

Autism in Adulthood welcomes well-supported, in-depth, analytic essays advancing theory, practice, or policy. Manuscripts should present a novel idea, develop a new conceptual theory or model, or synthesize the literature in an innovative way.

Advances in Methodology

Advances in Methodology manuscripts focus on methodologic issues in research on autism in adulthood. This article type purposefully allows for flexibility in how manuscripts are structured, so that authors can best present information to advance the field. For example, manuscripts may describe the processes used in a research project and discuss lessons learned or they may make evidence- or practice-based recommendations for why different methods are needed. We welcome evidence- or practice-based guidelines that advance research methods, processes, or approaches. Such manuscripts should explain the need for the new guidelines; describe how the guidelines were developed, including the evidence base and/or practice experience that guided them; provide the guidelines; describe how they advance the literature; explain where they may or may not apply; and discuss their implications for research, practice, and policy.

Emerging Practices

Autism in Adulthood welcomes well-referenced descriptions of innovative practices, grounded in theory, with lessons learned from their initial implementation or pilot-testing. Manuscripts should be organized as follows:

  1. Introduction (including why this emerging practice is needed)
  2. Theoretical Framework (describing how the practice is grounded in the literature)
  3. A description of the emerging practice, intervention, technology, or other advancement (note – authors may choose to name this section as appropriate)
  4. Evaluation Methods
  5. Lessons Learned (including evaluation data, observations from practice, and other lessons from initial implementation efforts)
  6. Discussion (including conclusions, how this work advances the literature, limitations, implications, and next steps).

Literature Reviews and Meta-Analyses

Whenever possible, Autism in Adulthood prefers systematic reviews, with or without a quantitative meta-analysis.

Systematic reviews and meta-analyses of quantitative evidence should follow the guidelines in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. PRISMA (an update and expansion of the QUOROM Statement) provides an evidence-based minimum set of items for reporting systematic reviews and meta-analyses. It can be found at http://www.prisma-statement.org The PRISMA Statement comes with a corresponding checklist and flow diagram that can aid authors in ensuring that their Systematic Review and/or Meta-Analysis has components found in a well-reported Systematic Review. Authors are strongly encouraged to submit the PRISMA checklist and flow diagram along with their manuscript. Also include the systematic review registration number and funding source.

Autism in Adulthood will consider the inclusion of high-quality narrative or clinical reviews when the question of interest is too broad, the body of evidence too sparse, or the topic too new or controversial for a systematic review. Narrative (non-systematic) or clinical reviews should address a clinical, educational, services, policy, or methodological problem. They should meld expert opinion with a thorough and balanced review of available evidence. Reviews of clinical topics should include references to relevant practice guidelines. Scoping reviews may also be appropriate for topics where the literature is still relatively scant.

Perspectives

Perspectives are well-referenced opinions or recommendations on topics related to research, practice, or policy. Authors should heavily cite the literature to make a clear, coherent argument. They should be transparent about their own positionality, experience, and expertise. Perspectives must synthesize and advance the literature in a novel way, through the author(s) own lens(es), not solely review the current state of the science.

Insights

Autism in Adulthood welcomes personal memoir-like essays from autistic adults, family members, professionals, or other stakeholders. The essay should be written for an academic audience and use citations, if appropriate, but it should be in the author’s own voice. The author should use their personal experiences to provide insights to others in the field. Essays may be in a variety of formats, including, but not limited to first-person narratives, creative non-fiction, poetry, and graphics.

Note: Insight Essay authors work directly with our Insight Essay Editors, Drs. Dora Raymaker and Ralph Savarese. If interested in potentially writing an Insight Essay, please contact the editorial office prior to writing the essay. Do not use the ScholarOne System to submit Insight Essay manuscripts.

Lay-language summary

Prepare a lay-language summary, of up to 500 words, highlighting the most important aspects of the manuscript. This summary should be aimed at what the lay public, including autistic adults, family members, practitioners, services providers, and policymakers, would want to know about the manuscript. Please use Plain Language and avoid or define technical terms.

Lay summaries should use a question and answer format. Lay summaries for Original Research should use the following headers: “Why was this study done?” “What was the purpose of this study?” “What did the researchers do?” “What were the results of the study?” “What do these findings add to what was already known?” “What are potential weaknesses in the study?” and “How will these findings help autistic adults now or in the future?”

Authors may use different question headers for other article types. For example, a lay summary for an Emerging Practices manuscript may use headers such as: “Why was this program developed?” “What does the program do?” “How did the researchers evaluate the new program?” “What were the early findings?” “What were the weaknesses of this project?” ”What are the next steps?” and “How will this work help autistic adults now or in the future?”. Similarly, headers for a Perspectives manuscript may include: “Why is this topic important?” “What is the purpose of this article?” “What is the perspective of the author(s)?” “What is already known about this topic?” and “What do the authors recommend?” and “How will these recommendations help autistic adults now or in the future?”

For more information on Plain Language, please see:

Abbreviations

Use only standard abbreviations, which can be found in the AMA’s Manual of Style for Authors and Editors, 10th edition  At first usage, spell out terms and provide abbreviations in parentheses. Thereafter, use only the abbreviations. It is not necessary to spell out standard units of measure. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and location in parentheses.

References  

Autism in Adulthood follows the AMA style. References must be prepared in Word, double spaced, and numbered consecutively as they are cited in the text. Include the reference section as part of the main text file, not as a separate file. References should be cited in the text in numerical order using superscript numbers without parentheses and placed outside of sentence punctuation. References appearing for the first time in tables and figures must be numbered in sequence with those cited in the text where the table or figure is mentioned. Use journal abbreviations as provided by PubMed/Medline. List all authors when there are six or fewer. When there are more than six authors, list the first three, followed by et al.

If references to personal communications or unpublished data are used, they are not to be in the list of references. They should be referred to in the text in parentheses with the researcher’s name and date: (e.g., AB Jones, personal communication, month and year of communication). Include among the references any articles that have been accepted but have not yet published; identify the name of publication and add "In Press." If the reference has been published online, provide the DOI number in place of the page range.

At this time, Autism in Adulthood does not yet have an output style in EndNote, but you may use the journal JAMA as a substitute as it follows the same reference style. Go to www.EndNote.com, search for “JAMA” and download the output style.*
*Note: The Publisher of Autism in Adulthood does not provide technical support for EndNote. If you have questions, click on the Support tab on EndNote’s website for assistance.

Sample style for references:

    Journal article:

Raymaker DM, Teo AR, Steckler NA, et al. "Having all of your internal resources exhausted beyond measure and being left with no clean-up crew": defining autistic burnout. Autism Adulthood. 2020;2(2):132-143.  

Siew CT, Mazzucchelli TG, Rooney R, Girdler S. A specialist peer mentoring program for university students on the autism spectrum: a pilot study. PLoS One. 2017;12(7):e0180854. https://doi.org/10.1371/journal.pone.0180854.

The preferred citation style for an electronic journal uses a DOI (digital object identifier). The DOI provides a persistent link to the electronic item and is considered to be more stable than a URL. If the DOI is not given on the full text article or in the citation, use a DOI Lookup Tool to locate it or use the format for an electronic article without a DOI.

    Book:

Wright SD, ed. Autism Spectrum Disorder in Mid and Later Life. London, UK: Jessica Kingsley Publishers; 2016.

    Chapter in a book:      

Crapnell T, Lau L, Hanks CD, Nicolaidis C, Kuo AA. Autism. In: Pilapil M, DeLaet DE, Kuo AA, Peacock C, Sharma N, eds. Care of Adults with Chronic Childhood Conditions: A Practical Guide. Switzerland: Springer International Publishing; 2016:53–65.

    Website:

National Joint Committee for the Communication Needs of Persons with Severe Disabilities (NJC.) History of the National Joint Committee. American Speech-Language-Hearing Association. https://www.asha.org/NJC/history  Last accessed August 27, 2020.

    Conference Proceedings:

Please follow this structure for Conference Proceeding references, including capitalization and punctuation:

List all Authors’ (or) Editors’ names (last name first, followed by first and middle initials). Conference title. Date of conference. Location of conference. City of publisher: Publisher; Year of publication. Complete number of pages in proceedings book.

    Preprint:

Preprints may be cited in the same manner as a journal article. Discretion is recommended as preprints are, by definition, not peer reviewed.

Figure Legends

Figure legends should be uploaded as a separate Word file and double spaced. In the legend, provide explanations for any abbreviations, arrows, etc. that appear in the figure. If the figure is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.

Tables

All tables should be prepared in one single Word file with each table presented on a new page. Upload one table file, containing all tables, under the “Table” file designation. Be sure to number each table within the file using Arabic numerals. Provide a brief descriptive title for each table. Cite tables in sequence in the text. Explain abbreviations and acronyms used in the body of the table in footnotes. All other types of table footnotes should be designated using superscript letters, not symbols. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. If the table is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.  

Figures

  • Submission of high resolution .TIFF or .EPS figure files is strongly recommended.
  • Prepare each figure as an individual file.
  • Figures should not be embedded within the manuscript file.
  • Cite figures consecutively in text within parentheses.
  • A legend should be supplied for each figure and all legends numbered consecutively.
  • Images should not show the name of a patient or a manufacturer.  
  • Do not include any illustrations as part of your text file.

Supplementary information

When appropriate, we encourage the judicious use of online-only supplementary information (SI). Refer to all information/data in the SI in the article text, including reference to specific tables and figures in the SI. Upload supplementary tables, figures, and legends as separate files, either as “supplementary file” or “supplementary file for review only.” The article that appears in the printed journal should contain all data which are key to the conclusions and important for the reader to have direct access to when reading the article. Other supporting data and text are appropriate for the supplementary section.

Correspondence Address

Following the references, provide the name and complete affiliation and institutional email address of the person to whom correspondence should be sent.

Manuscript Revisions

Do NOT create a new submission for revisions of already-submitted manuscripts. Detailed instructions for submitting revised manuscripts are provided in an email which is sent to the corresponding author along with the reviewers’ comments. Revised submissions routinely undergo further review by the same reviewers who assessed the original submission, members of the editorial board, and/or the editor(s). Contact the Editorial Office immediately if the deadline for your revised submission has expired. Please note that an invitation to revise any submission does not guarantee acceptance.

To upload a revision of a manuscript, the submitting author should log in to their Author Center and click on “Revised Manuscripts in Draft.” All revised submissions will be required to meet all formatting conditions described herein. Submissions that do not satisfy these requirements will be un-submitted and returned to the submitting author for proper configuration.

Letters to the Editor

Autism in Adulthood will consider Letters to the Editor commenting on the scientific content of an article published in the Journal. Letters should not exceed 500 words of text and 5 references. Letters submitted for publication must be original and must not be submitted to any other publication simultaneously.

Journal Policies on:

Licensing Information: OPEN ACCESS and Copyright
Data Sharing and Preprint Policies
Post-Acceptance and Post-Publication Policies
Correction Statements / Retractions
Reprints, Permissions, & Social Media Use
Plagiarism Detection Software
Definitions of Scientific Misconduct
Responding to Allegations of Scientific Misconduct
Press Embargo Policy
Publication Costs
Archiving and Preservation
Publisher Information

For questions regarding manuscript submissions, contact our Author Services Division.

 

Mary Ann Liebert, Inc., publishers has partnered with Editage and Impact Science to provide a dynamic suite of specialized editorial services to ensure your manuscript has the impact it deserves.

 

Make Your Manuscript Submission-Ready

English Language Editing Services
Our pre-submission English Language Editing Services pair you with a highly qualified native English-speaking editor within your specific field of study. Dedicated support includes a detailed review of grammar, punctuation, terminology, and spelling, as well as an intensive edit for organization. We also offer post-submission support where needed.

English-Language Translation with Editing Services
Write your paper in your native language and our expert team will provide you with a translation that meets international publication standards while preserving the science and accuracy of your manuscript. Our translators and editors offer subject-specific expertise and editing skills to ensure that your manuscript conveys every nuance of your research to a global audience.

 

Accelerate Your Research Impact

Research Promotion Services
Amplify your research with engaging infographics, video abstracts, plain language summaries, and more to ensure your manuscript is discovered, read, and cited. Our specialized team of communication experts, scientists, and designers will transform your research into impactful text, graphical, and audio-visual formats that resonate with a wider audience and increase engagement.

Visit our Author Services portal now for more information and to get started!

 

All Editage services are fee-based services that authors can opt-into as an added author benefit to amplify the readability, visibility, findability, and shareability of their work.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email openaccess@liebertpub.com.

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

 

Browse journals in the Liebert Open Access portfolio:

JOURNAL FEES

  • There are no submission fees to Autism in Adulthood.
  • There no page charges for Autism in Adulthood.
  • Autism in Adulthood is currently waiving fees for publishing images in color.
  • Open Access and Creative Commons licensing options are available. Contact our Open Access Manager for more information.
  • For pricing and purchasing reprints, contact our Reprints Manager.
  • Any fees collected or payments associated with a submitted and/or published paper that is subsequently withdrawn and/or retracted for any reason are non-refundable.

All Mary Ann Liebert, Inc. journals follow the standards, guidelines, and best practices set forth by the -Committee on Publication Ethics (COPE; publicationethics.org), the International Committee of Journal Medical Editors (ICJME; www.icmje.org), the World Medical Association (WMA); www.wma.net) and the American Medical Association (www.ama-assn.org).

Autism in Adulthood is a single-masked peer-reviewed journal. All submissions are subject to peer review. Upon submission, manuscripts are assessed by an editor for suitability for the journal.  For those that are deemed suitable, a minimum of two expert reviewers in the area of study will be selected to assess the scientific basis and significance of the manuscript. Following peer review, the Editor and/or Associate Editors will determine if the paper should be accepted, require revision, or is unacceptable for publication.

Confidentiality in Peer Review

Editors and reviewers must maintain strict confidentiality of manuscripts during the peer-review process. Sharing a manuscript in whole or in part, outside the scope of what is necessary for assessment, is impermissible prior to an accepted manuscript's official publication date.

Sharing of Materials during Peer Review

Authors must honor any reasonable request for materials, methods, or data necessary to reproduce or validate the research findings during peer review unless it violates the privacy or confidentiality of human research subjects.

Papers Authored by the Editor-in-Chief and/or Associate Editors

The Editor-in-Chief and Associate Editors will recuse themselves from participating in the review process of any manuscript in which there is a potential or actual competing interest.

Self-Citation and Self-Plagiarism

Autism in Adulthood is committed to maintaining the integrity of the peer review process by upholding the highest standards for all published articles. All manuscripts will be processed through plagiarism detection software prior to peer review. Plagiarized manuscripts will be rejected immediately. While a manuscript submission may contain some redundancy in language and content (i.e., Materials and Methods) compared to work previously published by authors, self-plagiarism can infringe upon copyright. To avoid plagiarism, be sure to properly cite and reference all published works. (Deposition of a preprint on a preprint server is not considered as prior publication and will not impact consideration of any submitted manuscript.)

Time in Review

Autism in Adulthood aims to maintain a short, but thorough peer-review process. The average time in review is 25 days.  However, the Editor(s) will strive to expedite manuscript handling if/when special circumstances dictate.

Word limits do NOT pertain to the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, or references.

Autism in Adulthood may also publish other manuscript types at the discretion of the Editors. Click here to discuss ideas for possible manuscripts that do not fit these categories.

Original Research Articles
Descriptions of rigorously conducted empirical research studies.    
•    3,000-word limit, except for qualitative studies, which can be up
to 4,000 words
•    Structured abstract of no more than 300 words

Brief Research Reports    
Concise, focused reports about original research.
•    1,500-word limit
•    Structured abstract of no more than 300 words
•    Maximum total of two (2) figures and/or tables

Conceptual Analysis    
Well-supported analytic essays advancing theory, practice, or policy.    
•    5,000-word limit    
•    Unstructured abstract of no more than 250 words

Advances in Methodology    
Evidence- or practice-based recommendations that advance research methods, processes, or approaches.    
•    5,000-word limit    
•    Unstructured abstract of no more than 250 words

Emerging Practices     
Well-referenced descriptions of innovative practices, grounded in theory, with lessons learned from their initial implementation or pilot-testing.    
•    3,000-word limit    
•    Unstructured abstract of no more than 250 words

Literature Reviews and Meta-analyses     
Systematic reviews are preferred; however high-quality narrative, clinical, or scoping reviews are welcome for topics not conducive to systematic review.
•    5,000-word limit
•    Systematic and scoping reviews and meta-analyses - structured abstract of no more than 300 words  
•    Narrative or clinical reviews - unstructured abstract of no more than 250 words

Perspectives     
Well-referenced opinions or recommendations on topics related to research, practice,
or policy.    

•    3,000-word limit    
•    Unstructured abstract of no more than 250 words

Insights     
Invited personal memoir-like essays from autistic adults or other stakeholders that provide important insights for the field.    
•    2,000-word limit    
•    No abstract

Editorials
Solicited by the Editor to accompany a manuscript to be published in Autism in Adulthood.
•    1,500-word limit
•    No abstract
•    No figures or tables
•    Maximum of 10 references

Letters to the Editor
Letters in response to articles published in Autism in Adulthood.
•    500-word limit
•    No abstract
•    May include one figure OR table
•    Reference citations are identical in style to those of full original articles, but should not exceed five (5).

Reviews of Books, Media, and Other Resources    
Brief reviews of books, media, or other resources of relevance to autism in adulthood. Solicited by the Editors.    
•    1,000-word limit (or greater at the discretion of the Editors)    
•    No abstract

 

ATTENTION:  To ensure the receipt of all communications from the journal editorial office and publisher, please whitelist the following domains to prevent spam filter detection or non-deliverables:

  • manuscriptcentral.com
  • amazonses.com
  • liebertpub.com

Failure to whitelist these domains may significantly hinder the progress of peer review on submitted manuscripts, and the production process of accepted papers.
 

AUTHORSHIP

Definition of Authorship

Authorship, as defined by the International Committee of Medical Journal Editors, is based on the following criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Non-Author Contributors

Contributors who meet fewer than all four of the above criteria for authorship should not be listed as authors, but they should be acknowledged in the Acknowledgments section with a description of their contribution to the work.

For further information, visit the International Committee of Medical Journal Editors’ website at: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

ORCID IDs

All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.

AUTHORSHIP LIMIT

There is a limit of 35 of authors permitted on a single submission, but in cases where there are 20 or more co-authors, Autism in Adulthood recommends that a collective group or consortium name be provided and the individual authors listed in the Acknowledgements.

CORRESPONDING AUTHOR**

One author should be designated as the corresponding author who will be responsible for communication between the authors and the journal editorial office(s) and publisher. This individual will be responsible for ensuring all authors submit copyright forms and coordinating and responding to page proofs, as well as any managing any other necessary contact during the peer review and/or production processes.

**NOTE: Due to configuration restraints, the submission system permits only one author to be identified as the corresponding author of record. However, we recognize that some submissions call for more than one corresponding author to be noted. In such cases, select one author to be the main point of contact and/or corresponding author for all communications regarding the peer review process of the paper, but on the title page of the manuscript, designate additional co-corresponding authors by including an asterisk after the authors' names in the byline, and include an accompanying footnote on the title page that reads, "*Co-corresponding authors."  Please ensure that the title page of the submission page carries the full affiliation details and email addresses of all authors who should be noted as a corresponding author. If the paper is accepted for publication, the full contact information for all desginated co-authors will be listed at the end of the article as per usual journal style.

WORKING GROUPS / TEAM AUTHORSHIP

Working Groups or Teams may be listed in the manuscript byline, but the entire listing of names and affiliations should be included in the acknowledgment section of the manuscript. Do not list the names in a footnote on the title page.

VARIATIONS OF AUTHORSHIP

It is permissible to list up to three authors as co-first authors, or as contributing equally to the work. Include an asterisk (*) next to the authors' names who are considered as first authors. Include a corresponding footnote, using the asterisk, on the title page that reads, "These authors contributed equally to this work and are considered to be co-first authors."

CHANGES IN AUTHORSHIP

Changes in authorship after submission or acceptance of a paper are strongly discouraged, but the editorial leadership recognizes that in certain circumstances, it may be required. The journal's policy for such cases is as follows:

  • A request to alter authorship must be made in writing from the corresponding author to the Editor-in-Chief, with a detailed explanation for the request, and the names and affiliations of the authors requiring addition and/or deletion.
  • Authorship may be altered after submission or acceptance of a paper ONLY with the expressed written approval of all authors named on the manuscript, as well as the individual(s) being added and/or deleted. The Publisher can provide a form for this, if needed.
  • Upon receipt of the request and all written approvals of all involved parties, the Editor-in-Chief will consider the request, render a decision, and notify the corresponding author.
  • There is a one-year post-publication statute of limitation on requests for alterations in authorship.
  • Post-publication changes or alterations to conference abstracts are prohibited.

ATTENTION: To ensure the receipt of all communications from the journal editorial office and publisher, please whitelist the following domains to prevent spam filter detection or non-deliverables:

  • manuscriptcentral.com
  • amazonses.com
  • liebertpub.com

Failure to whitelist these domains may significantly hinder the progress of peer review on submitted manuscripts, and the production process of accepted papers.

EXCLUSIVITY

Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, in the same form or substantially similar form, except in the form of a conference abstract.  If work was presented at a conference, supply the name, date, and location of the meeting as a footnote on the title page of the submission.

AUTHOR DISCLOSURE STATEMENTS

  • Competing Interests. A competing interest exists when an individual (or the individual's institution) has financial or personal relationships that may inappropriately influence his actions. These competing interests may be potential or actual, financial or other.
  • Personal Financial Interests. Stocks or shares in a company that may gain or lose financially from publication of the article; consulting fees or other remuneration from an organization that may gain or lose financially from publication of the article; patents or patent applications that are owned by or licensed to companies/institutions that may gain or lose value from publication of the article.
  • Funding. Research support by organizations that may gain or lose financially from publication of the article. This support includes salary, equipment, supplies, honoraria, reimbursement or prepayment for attending symposia, and other expenses.
  • Employment. Recent (within the past 5 years), current, or anticipated employment by an organization that may gain or lose financially from publication of the article.
  • Other Competing Interests. Any personal relationship which may inappropriately affect the integrity of the research reported (by an author) or the objectivity of the review of the manuscript (by a reviewer or Editor), for example, competition between investigators, previous disagreements between investigators, or bias in professional judgment.

SELF-CITATION AND SELF-PLAGIARISM

Autism in Adulthood is committed to maintaining the integrity of the peer review process by upholding the highest standards for all published articles. All manuscripts will be processed through plagiarism detection software prior to peer review. Plagiarized manuscripts will be rejected immediately. While a manuscript submission may contain some redundancy in language and content (i.e., Materials and Methods) compared to work previously published by authors, self-plagiarism can infringe upon copyright. To avoid plagiarism, be sure to properly cite and reference all published works.

AFFILIATIONS

Authors should identify as their institution(s) the facility where the work was performed and executed.  Changes in an author’s affiliation after the work was completed but prior to the submission or publication of the manuscript should be noted by including an asterisk as a superscript to the name in the author listing, as well as a corresponding footnote on the title page indicating “Current Address” listing the new affiliation.   Corrections to affiliations or contact information due to relocation after publication is not permitted.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany the proofs and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher as reprints ordered after the issue is printed will be charged at a substantially higher rate.

INTERNAL REVIEW BOARD APPROVALS/WAIVERS (as described and defined on the World Medical Association's website; www.wma.net)

When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the Declaration of Helsinki as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.

If the study is judged exempt from review, a statement from the committee is be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and in a sentence declaring adherence should be included at the beginning of the Materials and Methods section of the manuscript.

HUMAN SUBJECTS:  PATIENT CONSENT / RELEASE
If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images and/or information of patients.

Any identifying information should not be published in descriptions or photographs unless the information is essential for scientific purposes and the patient (or parent/guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be submitted. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.  Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, the manuscript should contain assurances/statements that such changes do not distort scientific meaning.

In keeping with patients' rights of privacy, the Journal does not require the submission of patient consent forms, but instead requires the author(s) to retain and archive all patient consent documentation. Upon submission of a manuscript for review, the authors must make a statement in a cover letter to the Editor/Journal which attests they have received and archived written patient consent.  A statement of patient consent must be included in the Methods section of the manuscript.

ETHICAL TREATMENT OF ANIMALS

All peer-reviewed submissions containing animal experiments must comply with local and national regulatory principles and contain a statement in the Materials and Methods section stating whether their national and institutional guidelines for the care and use of laboratory animals were followed.

 

 

Each author listed on original submissions should disclose any and all conflicts of interest, whether they are actual or potential.    Visit the International Committee of Medical Journal Editors (ICMJE) website for further guidance.   Some examples of conflicts of interest are, but not limited to, the following:

  • Competing Interests. A competing interest exists when an individual (or the individual's institution) has financial or personal relationships that may inappropriately influence his actions. These competing interests may be potential or actual, financial or other.
  • Personal Financial Interests. Stocks or shares in a company that may gain or lose financially from publication of the article; consulting fees or other remuneration from an organization that may gain or lose financially from publication of the article; patents or patent applications that are owned by or licensed to companies/institutions that may gain or lose value from publication of the article.
  • Funding. Research support by organizations that may gain or lose financially from publication of the article. This support includes salary, equipment, supplies, honoraria, reimbursement or prepayment for attending symposia, and other expenses.
  • Employment. Recent (within the past 5 years), current, or anticipated employment by an organization that may gain or lose financially from publication of the article.
  • Other Competing Interests. Any personal relationship which may inappropriately affect the integrity of the research reported (by an author) or the objectivity of the review of the manuscript (by a reviewer or Editor), for example, competition between investigators, previous disagreements between investigators, or bias in professional judgment.

RESEARCH FUNDER COMPLIANCE (FundRef)

Upon submission of a manuscript, the submitting agent will have an opportunity to enter funding/grant information. If funding information is entered correctly, the publisher will deposit the funding acknowledgements from the article as part of the standard metadata to FundRef. The entered information should include funder names, funder IDs (if available), and associated grant numbers.  Special care should be taken when entering this information to ensure total accuracy. (See https://www.crossref.org/services/funder-registry/ for a listing of more than 13,000 international funding agencies.)

GOVERNMENT FUNDED RESEARCH

Autism in Adulthood is fully NIH-, HHMI-, RCUK, and Wellcome Trust-compliant.

OPEN ACCESS

Our open access publishing solutions allow you to comply with the open access policies of your institution, government, and funding body. If you are employed or funded by the National Institute of Health (NIH), the Wellcome Trust, Research Councils UK (RCUK), or Howard Hughes Medical Institute (HHMI), you can find more information below:

  • NIH and HHMI Public Access Policy–In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final paginated version of the published article to PubMed Central (PMC) on behalf of the authors after a 12-month embargo period. Authors need not take any action. This service is provided free of charge. Authors who wish to remove the 12-month embargo period are encouraged to consider publishing with Open Option.
  • Wellcome Trust Policy–To easily comply, you can choose to have your article published open access under the Creative Commons Attribution (CC BY) license. The publication charge will be covered by the Wellcome Trust.
  • Research Councils UK (RCUK)–To easily comply, you can choose to have your article published Open Access under the Creative Commons Attribution (CC BY) license. The publication charge will be covered by the RCUK.

DATA SHARING

Autism in Adulthood strongly advocates the sharing and archiving of the data and any other artifacts that define and support the results stated in a manuscript in a suitable public repository (in accordance with valid privacy, legal, and ethical guidelines). A data availability statement should be included in the manuscript (in the Methods section or as a separate section at the end of the manuscript), describing the location of the data, with details on how it can be accessed as well as any licensing information. If the data is not publicly available or accessible, that information should also be provided.

Datasets should be cited in the reference list by Author (Year). Title. Publisher. Identifier/DOI.

Important: Please check with your funding agencies to ensure that are you following their data sharing polices. If your funding agency has additional requirements exceeding our policy, you must follow the requirements of your funder.

PREPRINT SERVERS

A preprint is a complete draft of a research paper that is shared on a public preprint server prior to submission to a journal for peer review.
 
Mary Ann Liebert, Inc., allows for papers that were previously deposited on preprint servers to be submitted to our journals, with the proviso that the author updates any preprint versions with a link to the final published article.  All submissions are subject to peer review and allowing the submission of preprint manuscripts does not guarantee publication in any Mary Ann Liebert, Inc., journal.
 
The submitting author of a paper that was previously deposited to a preprint server should include a disclosure on the title page of the manuscript indicating the name and website of the server and include the DOI number of the preprint.
 
Referencing/citing non-peer-reviewed material that is found on any preprint server is generally discouraged by Mary Ann Liebert, Inc., journals, but if it is necessary, the citation must make it clear that the content is not officially published in a journal, and can only be found on a preprint server.

 

Three versions of the article format versions are referenced in the below policy guidelines:

•    Original Submission: The article version that is submitted by the author for consideration, before peer review.
•    Accepted Version: The article version that has been formally accepted after peer review, prior to any typesetting for the journal. This is the version accepted by the editor, before proofs, corrections, and typesetting. Also known as the “raw” accepted version of a manuscript.
•    Article of Record: This article version is the “version of record” that has been formally copyedited, typeset, and published online epub ahead of print and/or in a journal issue. It is the same version published in the “Online Now” section of the journal website.

Self-Archiving Policy

Mary Ann Liebert, Inc., publishers offers authors many options and opportunities to self-archive their work. Self-archiving of work is also referred to, or known as, publishing “Green Open Access”.

Authors can self-archive the original submission version of their article on any website or repository without embargo.

Additionally, authors can self-archive the accepted version of their article on their personal websites or institutional repositories only, without embargo. Any archiving of the accepted version for inclusion in subject-based repositories, such as PubMed Central (PMC), should follow the requirements of the funder of the work.  

Authors are not allowed to publish or self-archive the article of record on any website, social media platform, or repository without permission from Mary Ann Liebert, Inc., publishers, unless they publish their paper Gold Open Access (OA). Learn more about publishing your work Open Access here.

Mary Ann Liebert, Inc., publishers’ society partners or associated affiliates may set self-archiving policies independently, outside of the below -mentioned general policies. Authors should refer to the copyright policy of their chosen journal, which can be found on the Journal Collection Page or by contacting the specific journal editorial office directly. In addition, specific funding organizations have separate agreements and authors should refer to the policies of those specific funding agencies prior to the submission of their manuscript.

Original Submission Version

The original submission version of an article is the author's version that has not been peer reviewed.

This version may be placed on:

•    The author's personal website
•    The author's company or institutional repository or archive
•    Any not-for-profit subject-based preprint servers or repositories

Self-archiving of the original submission version is not subject to an embargo period.

If your submission is formally accepted after peer review in one of our journals, authors must include an acknowledgement of acceptance for publication on all archive sites and, following online publication, authors must include the following notice on the first page:

This is the original submission version (pre-peer review) of the following article: [full citation], which has now been formally published in final form at Autism in Adulthood at [link to final article using the DOI]. This original submission version of the article may be used for non-commercial purposes in accordance with the Mary Ann Liebert, Inc., publishers’ self-archiving terms and conditions.

The original submission version posted may never be updated or replaced with the article of record version unless the author chooses to publish their paper OA under any of the Creative Commons Licenses available through the publisher. If you are interested in publishing your work OA, please feel free to review our Open Access policies and Licenses or contact us.

Accepted Version

Authors may only archive the accepted version of their manuscript on their personal and professional websites, and/or the author’s institutional repository or archive. Any archiving of the accepted version for inclusion in subject-based repositories, such as PubMed Central (PMC), should follow the requirements of the funder of the work. This process may impose additional embargo periods.  

The accepted version may be placed on:
•    The author's personal website
•    The author's company/institutional repository or archive

The accepted version posted must include the following notice on the first page:

This is the accepted version of the following article: [full citation], which has now been formally published in final form at Autism in Adulthood at [link to final article using the DOI]. This original submission version of the article may be used for non-commercial purposes in accordance with the Mary Ann Liebert, Inc., publishers’ self-archiving terms and conditions.

The posted accepted version may never be updated or replaced with the article of record version unless the author chooses to publish their paper Open Access under any of the Creative Commons Licenses available through the publisher. If you are interested in publishing your work OA, please feel free to review our Open Access policies and Licenses or contact us.

Article of Record

The article of record version may never be archived on a website, or in a repository or research network, unless published Gold Open Access under any of the Creative Commons Licenses available through the publisher. If you have questions, please contact us for more information. You can also review our Open Access policies and Licenses.

Funder Requirements

Mary Ann Liebert, Inc. publishers adheres to national and international funder requirements. Various funders, such as the National Institutes of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI), The Bill & Melinda Gates Foundation, and UK Research and Innovation (UKRI), for example, have specific requirements for depositing the accepted version and/or the article of record version of the author manuscript in a repository after an embargo period. Authors funded by these organizations should follow the self-archiving terms and conditions of these separate agreements based on the policies of the specific funding institutions. If you have questions, please contact us for more information.

Terms and Conditions for Use of All Self-Archived Article Versions

Authors may use either the original submission version or accepted version in the following ways:

•    For purposes of your own curriculum or teaching, dissertation, thesis, or book provided that all posted versions include the aforementioned notices, and follow all guidelines and requirements specified.
•    To share with researchers and research colleagues provided that such sharing is not for commercial purposes.

The self-archived submitted and accepted versions may only be used in non-commercial capacities. Individual users may view, print, download, and copy self-archived articles, as well as text and data mine the content conditions for non-commercial and non-promotional research and private study purposes, under the following requirements:

•    The authors' moral rights are not compromised and there is clear "attribution" of the author(s) in the shared work.
•    The authors’ integrity remains intact; the work should never be altered in such a way that the author's reputation or integrity may be damaged.
•    Any reuse complies with the copyright policies of the owner of that content.
•    Self-archived content may never be republished verbatim in whole or in part in print or online formats.

 

 

ATTENTION: To ensure the receipt of all communications from the journal editorial office and publisher, please whitelist the following domains to prevent spam filter detection or non-deliverables:

  • manuscriptcentral.com
  • amazonses.com
  • liebertpub.com

Failure to whitelist these domains may significantly hinder the progress of peer review on submitted manuscripts, and the production process of accepted papers.

POST-ACCEPTANCE / PRODUCTION

All accepted manuscripts will go through copyediting, typesetting, figure sizing and placement, author proofing, corrections, revisions (from corrected proofs), online-ahead-of-print release, and lastly, issue assignment. Depending on the length and complexity of any accepted submission, these steps typically take 3-6 weeks from acceptance.  Changes or alterations to a submission are not permitted after acceptance, but should be addressed in page proofs.

PAGE PROOFS

Page proofs will be sent to the corresponding author as designated in Manuscript Central when the manuscript was submitted. It is the corresponding author's responsibility to share the page proofs with co-authors, if desired, and to coordinate all authors' corrections into one proof. The Publisher will not accept corrections from multiple authors/sources.

AUTHOR RESPONSE TO GALLEY PROOF

  • The corresponding author is responsible for returning corrected galley proofs generally within 72 hours of receipt.
  • If the corresponding author does not respond within that timeframe, the manuscript may be delayed in the publication schedule, or published as is, at the discretion of the Editor and Publisher.
  • If the corresponding author expects to be unavailable during the time the manuscript is in production, the publisher should be provided with an alternate contact. 
  • Only corrections directly related to errors in typesetting and/or layout will be allowed.
  • Any requested changes related to content, or that alter the outcome of a study, will require the approval of the Editor, and may require further peer review.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany the proofs and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher as reprints ordered after the issue is printed will be charged at a substantially higher rate.

POST-PUBLICATION CORRECTIONS

In the event an error is discovered after publication of an article, the corresponding author should submit the correction in writing to the Editor for consideration.  After editor approval, alterations will be made to the online version of the article, and if the errors are significant, an official correction statement will be issued.  Note the following:

•    Changes to author affiliations or contact details due to relocation after publication are not permitted.
•    Corrections to meeting abstracts will be made only to the online version.  The Journal does not issue formal correction statements for corrections to meeting abstracts, regardless of the nature of the correction.
•    Correction Statements/Errata to published articles that require the reproduction of color figure(s) and/or table(s) may incur additional costs to the author(s).

RETRACTIONS**

The journal and its publisher are committed to upholding the proper protocols and established standards of peer review.  Published papers found to be in violation of any of the in the accepted principles of peer review and scientific publishing will be officially retracted from the literature.  An official retraction notice explaining in full detail the circumstances surrounding the need for a retraction will be published.

**Any publication fees for retracted and/or withdrawn articles are nonrefundable in any circumstance.

COPYRIGHT AGREEMENT FORM

Upon acceptance of any manuscript, all authors will receive an email with detailed instructions and a unique, author-specific link to access and complete our online Copyright Agreement form. It is critical to ensure the accuracy of ALL authors' email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications. FAILURE BY ALL AUTHORS TO SUBMIT THIS FORM WILL RESULT IN A DELAY OF PUBLICATION. The corresponding author is responsible for communicating with coauthors to ensure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright. Copyright forms may also be completed by logging in to the system using an author's credentials. After logging on, click on Author Center and complete the forms located under "Manuscripts I Have Coauthored."

Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc., unless alternate arrangements are made prior to publication, including CC-BY licensing (see below). By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.

OPEN ACCESS / CC-BY LICENSING

Autism in Adulthood is a subscription-based peer-reviewed journal with Open Access options. Creative Commons CC-BY and CC-BY-NC licensing is available for all articles published open access for a standard Article Processing Charge (APC) of $3,200.00 USD. Please contact our Open Access Manager to order open access for your article. Learn more about open access publishing on our website.

PERMISSIONS

When reproducing copyrighted material such as figures, tables, or excerpted text, the author(s) of the submitted paper must obtain permission from the original publisher and submit it concurrently with the manuscript. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote to a reprinted table or the legend of a reprinted figure should read, "Reprinted by permission from Jones et al." and list the appropriate reference. All permissions must be supplied at the time of submission.  Authors are responsible for any fees that may be incurred by securing permission to reproduce or adapt material from other published sources.

REUSE OF MATERIAL POSTED ON SOCIAL MEDIA

As material posted on social media platforms is usually not peer-reviewed content, it is not permitted as an official citation and/or reference.

Mary Ann Liebert, Inc., publishers follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).

Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
  • Authorship Disputes: Deliberate misrepresentation of a scientist's contribution to the published work, or purposefully omitting the contributions of a scientist.
  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
  • Material failure to comply with legislative and regulatory requirements affecting research: Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
  • Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
  • Plagiarism: Purposely claiming another's work or idea as your own constitutes misconduct and/or fraud.
  • Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.

Retractions

The journal and its publisher are committed to upholding the proper protocols and established standards of peer review.  Published papers found to be in violation of any of the misconduct noted above, or in the accepted principles of peer review and scientific publishing, will be officially retracted from the literature.  An official retraction notice explaining in full detail the circumstances surrounding the need for a retraction will be pubished.

The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All allegations will be kept confidential.

 

 

Retraction Notices / Expressions of Concern

The Publisher is committed to protecting the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct appropriate investigations into any reported allegations. As such, all allegations of misconduct will be referred to the Editor-in-Chief of the Journal who in turn will review the circumstances, possibly in consultation with Executive Editors, Senior Editors, Associate Editors, and/or other members of the editorial board as needed.  Initial investigations and fact-finding will include a request to all involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-in-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an Editor, an outside expert. The Editor-In-Chief and/or the Publisher may consult with our Ethics Editor(s) and will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations arise, the peer review and publication process of the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the paper is withdrawn by the authors or Editor(s). In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.  If the paper is still under peer review, the Editor-in-Chief reserves the right to withdraw the paper from consideration to the Journal.

If the accusation is with regards to a published paper, the Journal/Publisher reserves the right to publish an official “Expression of Concern” statement while the investigation is still underway.  This statement will contain the full circumstances of the complaint and will be placed directly above the published Abstract in the online version of the article.  If the investigation is not resolved by the time the next print issue of the journal is to be published, the Expression of Concern will be published as official content in the print issue.

If the investigation determines clear misconduct, the Editor-in-Chief and Publisher will officially retract the paper from the Journal and the scientific record by publishing a formal Retraction Notice both online and in print. This notice will contain all relevant details of the accusation, investigation, and the resulting conclusions.

The official Retraction Notice will replace the abstract in the online version of the article as well as in the PDF.  In addition, each page of the PDF will be watermarked with “Retracted.” The Retraction will be delivered to all associated indexing services affiliated with said journal (i.e. PubMed Central, PubMed/MEDLINE, Web of Science, etc.).

In the case where an investigation determines that no misconduct occurred, the Expression of Concern will be updated accordingly but will remain intact as part of the article and will not be removed so that readers will be notified that concerns were raised.

Editors, authors, or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal and reported to their institution.

Every attempt will be made to keep all allegations confidential.

Mary Ann Liebert, Inc., deposits and archives all publications in Portico for long-term digital preservation. Your article will be easily searchable on Google, Google Scholar, and other search engines.

Mary Ann Liebert, Inc., publishers permits the use of accepted pre-published manuscripts for the sole purpose of pitching to news organizations under strict embargo, and with the approval of and expressed collaboration with the publisher. A watermarked PDF version of the article (not a Word document or any other editable version) may be shared only with named, personal contacts at trusted news sources upon request. News sources must be informed upon delivery of the PDF that the manuscript is for reference-only purposes and can be used only in preparation of their news coverage of the article. It is strictly prohibited to publicly share, post, or otherwise distribute the PDF in any media format. Upon official publication of the article, news organizations must link directly to the published article on the publisher’s journal website. To coordinate publication timing and press efforts, please contact the Director of Marketing.

The Office of Foreign Assets Control (OFAC) of the US Department of the Treasury administers and enforces economic and trade sanctions based on US foreign policy and national security goals against targeted foreign countries and regimes, terrorists, international narcotics traffickers, those engaged in activities related to the proliferation of weapons of mass destruction, and other threats to the national security, foreign policy or economy of the United States. (Source: https://www.treasury.gov/about/organizational-structure/offices/pages/office-of-foreign-assets-control.aspx)

Our journal editors welcome contributions from researchers around the world; however, they are also required to follow sanction laws and regulations. Upon the date of this update (August 2020), sanction measures imposed by the United States, United Nations, European Union, and Australia are currently in place against the following countries: Cuba, Crimea, Iran, North Korea, and Syria. Journal editors will treat with caution any submission from a sanctioned country regarding the subject matter and will seek appropriate legal advice from the publisher if necessary.

Papers from sanctioned countries that are submitted to any Mary Ann Liebert, Inc., journal MUST contain a confirmation statement after the conclusion section of the manuscript which indicates that EACH listed author confirms that their research is supported by an institution that is primarily involved in education or research.

For further questions, please contact our Director of Production and Editorial Operations.

Autism in Adulthood is owned and published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801; Tel: 914-740-2100; Email: Info@liebertpub.com; Website: www.liebertpub.com/AUT

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Upcoming Events